News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
830,379 Results
Type
Article (85561)
Company Profile (744)
Press Release (744074)
Section
Business (232235)
Career Advice (4102)
Deals (39641)
Drug Delivery (115)
Drug Development (90631)
Employer Resources (194)
FDA (17974)
Job Trends (17269)
News (395537)
Policy (39615)
Tag
Academia (2975)
Alliances (56425)
Alzheimer's disease (1327)
Approvals (17872)
Artificial intelligence (149)
Bankruptcy (394)
Best Places to Work (12492)
Biotechnology (507)
Breast cancer (125)
Cancer (1083)
Career advice (3510)
Cell therapy (248)
Clinical research (71339)
Collaboration (376)
Compensation (190)
COVID-19 (2796)
C-suite (96)
Data (1007)
Diabetes (161)
Diagnostics (6659)
Drug pricing (102)
Earnings (94479)
Employer resources (167)
Events (126513)
Executive appointments (282)
FDA (18473)
Funding (333)
Gene therapy (183)
GLP-1 (688)
Government (5044)
Healthcare (20707)
Infectious disease (2886)
Inflammatory bowel disease (118)
Interviews (807)
IPO (17574)
Job creations (5178)
Job search strategy (2853)
Layoffs (486)
Legal (10041)
Lung cancer (177)
Manufacturing (186)
Medical device (14397)
Medtech (14402)
Mergers & acquisitions (22084)
Metabolic disorders (450)
Neuroscience (1608)
NextGen Class of 2024 (7656)
Non-profit (5063)
Northern California (1380)
Obesity (261)
Opinion (242)
Patents (105)
People (64080)
Pharmaceutical (147)
Phase I (21953)
Phase II (30973)
Phase III (23365)
Pipeline (336)
Postmarket research (3539)
Preclinical (9920)
Radiopharmaceuticals (256)
Rare diseases (221)
Real estate (7371)
Regulatory (25907)
Research institute (2640)
Resumes & cover letters (648)
Southern California (1233)
Startups (4274)
United States (13637)
Vaccines (648)
Weight loss (216)
Date
Today (164)
Last 7 days (1018)
Last 30 days (3657)
Last 365 days (38241)
2024 (34047)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (224)
Asia (49285)
Australia (8681)
California (3222)
Canada (1237)
China (246)
Colorado (141)
Connecticut (156)
Europe (112854)
Florida (433)
Georgia (118)
Illinois (405)
Indiana (208)
Kansas (103)
Maryland (602)
Massachusetts (2664)
Michigan (168)
Minnesota (285)
New Jersey (937)
New York (934)
North Carolina (815)
Northern California (1380)
Ohio (139)
Pennsylvania (816)
South America (1647)
Southern California (1233)
Texas (461)
Washington State (379)
There are 830,379 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
November 12, 2024
·
8 min read
Press Releases
Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial with ORX750, a Novel Orexin Receptor 2 (OX2R) Agonist
November 12, 2024
·
4 min read
Press Releases
Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
November 12, 2024
·
11 min read
Press Releases
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
November 12, 2024
·
11 min read
Press Releases
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
November 12, 2024
·
19 min read
Press Releases
Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions
November 12, 2024
·
7 min read
Press Releases
Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
·
9 min read
Press Releases
Quanterix Releases Preliminary Financial Results for the Third Quarter of 2024
November 12, 2024
·
13 min read
Press Releases
Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress
November 12, 2024
·
14 min read
Press Releases
TherapeuticsMD Announces Third Quarter 2024 Financial Results
November 12, 2024
·
4 min read
1 of 83,038
Next
